Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?

Clinical and economic outcomes with appropriate or partial prophylaxis.

INTRODUCTION Despite the existence of evidence-based guidelines for venous thromboembolism (VTE) prevention, prophylaxis is often inappropriately prescribed. This study compared the efficacy, safety, and cost of appropriate (ACCP-recommended) prophylaxis with partial prophylaxis (not completely conforming to ACCP guidelines) in patients at-risk of VTE receiving enoxaparin or unfractionated hepa...

Prophylaxis of venous thromboembolism - The guidelines are there.

O tromboembolismo venoso (TEV) nas suas formas mais frequentes -trombose venosa profunda (TVP) e embolia pulmonar (EP) -é um problema bem reconhecido nos doentes hospitalizados como a primeira causa de morte intra-hospitalar evitável e como gerador de elevada morbilidade aguda e crónica1. A aplicação das recomendações existentes sobre a prevenção do TEV assume assim grande importância nos doent...

Venous Thromboembolism Prophylaxis in Cancer Patients

Venous Thromboembolism (VTE) is a common disease, comprising the life-threatening pulmonary embolism (PE) and its precursor deep vein thrombosis (DVT). In view of the clinically silent nature of VTE; the incidence, prevalence and mortality rates are probably under estimated (Kniffin et al., 1994). Although VTE is a common disease, fortunately it is preventable; identifying high risk patients an...

Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

In patients with venous thromboembolism (VTE), the outcome during the course of anticoagulant therapy may differ according to the patient's sex. We used the RIETE (Registro Informatizado Enfermedad TromboEmbólica) database to compare the rate of VTE recurrences, major bleeding, and mortality due to these events according to sex.As of August 2013, 47,499 patients were enrolled in RIETE, of whom ...

Venous thromboembolism prophylaxis and treatment in patients with cancer.